Ketamine is habit-forming. While it doesn’t create the same intense physical dependence as opioids or alcohol, it produces psychological cravings and tolerance builds quickly, leading many regular users to escalate their doses over time. The combination of rapid-onset euphoria, dissociation, and emotional numbing makes it reinforcing enough that some people develop patterns of compulsive use that are difficult to break.
How Ketamine Becomes Habit-Forming
Ketamine’s appeal lies in how fast it works. Within minutes, it blocks certain receptors in the brain involved in pain signaling and conscious awareness, producing feelings of euphoria, heightened sociability, and a sense of detachment from reality. For people dealing with emotional pain, trauma, or depression, that rapid escape can become powerfully reinforcing.
Tolerance develops quickly. Animal studies show it evolves rapidly, and clinical reports dating back to the 1980s documented patients needing higher doses to achieve the same anesthetic effect after repeated treatments. For recreational users, this means the dose that produced a strong dissociative experience early on stops working at the same level, pushing people to use more and more frequently. That escalation is one of the clearest markers of a developing habit.
There’s also a self-reinforcing cycle that can trap users. Ketamine has painkilling properties, so when chronic use starts causing physical problems (bladder pain, for example), some people increase their use to manage that pain, which worsens the underlying damage. This paradox makes it especially difficult to stop without outside help.
Psychological Dependence vs. Physical Withdrawal
The habit-forming nature of ketamine is primarily psychological. People develop strong cravings, use it to cope with stress or emotional distress, and find it increasingly difficult to feel normal without it. The psychological withdrawal symptoms include anxiety, panic, irritability, mood swings, depression, difficulty concentrating, intrusive thoughts, and emotional numbness.
Physical withdrawal symptoms do occur, though they tend to be milder than those associated with opioids, benzodiazepines, or alcohol. People stopping regular ketamine use report fatigue, sweating, muscle aches, nausea, tremors, chills, dizziness, rapid heart rate, headaches, and disrupted sleep. These physical symptoms aren’t typically dangerous, but combined with the psychological cravings, they can make quitting difficult without support.
Ketamine also shows cross-tolerance with several other substances, including alcohol and certain synthetic opioids. This means people who already use those substances may need higher ketamine doses to feel its effects, and it raises the possibility that ketamine use could complicate existing substance use patterns.
Who Is Most at Risk
Not everyone who uses ketamine develops a habit, but certain profiles carry higher risk. People with a history of substance use disorders are more vulnerable, which is why the FDA requires clinicians to assess abuse risk before prescribing ketamine-based treatments. A history of trauma, PTSD, grief, or depression also increases risk, because ketamine’s dissociative and mood-altering effects can become a coping mechanism that’s hard to replace.
In documented cases, patients who developed problematic ketamine use often had co-occurring psychiatric conditions that both drove the initial use and made it harder to stop. One case involved a man with long-standing ketamine use who chose it over other drugs because of its low cost and accessibility. Another involved a woman with childhood trauma and PTSD who began using ketamine recreationally to cope after the death of a close friend. In both situations, the emotional relief ketamine provided made it feel indispensable, and psychiatric conditions delayed recognition of the problem.
What Chronic Use Does to the Body
Beyond the habit itself, regular ketamine use causes real physical damage. The most well-documented consequence is severe bladder inflammation, sometimes called “ketamine bladder.” Chronic users develop symptoms including blood in the urine, urgent and frequent need to urinate, bladder pain, and dramatically reduced bladder capacity. In some cases, the bladder lining develops ulcers. Heavy users can also experience reflux of urine back toward the kidneys and long-term kidney damage.
These bladder problems can appear in users as young as their twenties and may not fully reverse even after stopping. The severity correlates with how much and how long someone has been using, which is another reason the rapid tolerance development is so dangerous: it pushes people toward the doses most likely to cause lasting harm.
How Medical Use Manages the Risk
The FDA approved a ketamine-based nasal spray (esketamine) for treatment-resistant depression in 2019, but with unusually strict controls. It’s classified as a Schedule III controlled substance and is only available through a restricted program designed specifically to prevent habit formation and diversion.
Every dose is administered in a certified healthcare setting, never at home. Patients spray the medication themselves but do so under direct observation from a healthcare provider, then remain monitored for at least two hours afterward. The medication never leaves the clinic. Pharmacies can only dispense it to certified treatment facilities, not directly to patients.
Clinicians are required to evaluate each patient’s history of substance use before starting treatment and to watch for drug-seeking behavior throughout therapy. People with a history of substance use disorders face additional scrutiny before being approved for treatment. These safeguards exist precisely because ketamine’s habit-forming potential is well established, and the medical community treats it accordingly.